Tag: Gene Therapy

The Government of India submitted a draft amendment on cell therapies

stem cells
The Ministry of Health and Family Welfare of India, after consultations with the Drugs Technical Advisory Board (DTAB), has proposed a draft amendment that defines stem cell-based products (SCBP).

GSK passes its portfolio of rare disease gene therapies to Orchard Therapeutics

gene therapy
GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for patients.

Lonza launched its dedicated cell-and-gene-therapy facility in USA

lonza building
Lonza opened the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies.

Novartis buys gene therapy company AveXis

Novartis announced that it has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based clinical stage gene therapy company for $8.7 billion.

Oxford BioMedica intends to obtain financing for further expansion

Oxford BioMedica, a leading gene and cell therapy company, intends to raise approximately $28,4 million to fund the expansion of its bioprocessing facilities.

Gilead and Sangamo joined up for development of next gen cell therapies

Kite, a Gilead Company, and Sangamo Therapeutics entered into a worldwide collaboration using Sangamo’s zinc finger nuclease (ZFN) technology platform for the development of next-generation ex vivo cell therapies in oncology.

AbbVie and Voyager Therapeutics set up a partnership

abbvie office
AbbVie and Voyager Therapeutics entered into a collaboration to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and other neurodegenerative diseases.

MilliporeSigma received two patents for its CRISPR technology

MilliporeSigma announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting MilliporeSigma's patent applications for the company's CRISPR technology

Novartis exclusively licensed gene therapy drug

Novartis announced a licensing agreement with Spark Therapeutics covering development, registration and commercialization rights to voretigene neparvovec in markets outside the US

Fujifilm opens a new cutting-edge manufacturing facility

gene therapy
FUJIFILM Diosynth Biotechnologies, a leading CDMO with experience focused on the development and manufacture of recombinant biopharmaceuticals, announced the opening of its Flexible Manufacturing Facility

Sangamo and Pfizer collaborate on new gene therapy

gene therapy
Sangamo Therapeutics and Pfizer Inc. announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors

Orchard Therapeutics and Genethon form a strategic alliance

gene editing
Orchard Therapeutics announced a strategic alliance with Généthon to develop gene therapy for X-linked chronic granulomatous disease

bluebird bio and TC BioPharm entered into research collaboration

gene therapy
bluebird bio and Scottish immunotherapy company TC BioPharm announced a strategic collaboration and license agreement focused on gamma delta CAR T cells

FDA approved second gene therapy product

gene therapy
The U.S. Food and Drug Administration yesterday approved Yescarta, a cell-based gene therapy